Drug Information

Drug General Information
Drug ID
D0TH0Z
Drug Name
Selumetinib
Drug Type
Small molecular drug
Indication Melanoma [ICD10:C43-C44] Phase 3 [1572593]
Formula
C17H15BrClFN4O3
PubChem Compound ID
10127622
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 1572593ClinicalTrials.gov (NCT01933932) Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC (SELECT-1)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.